iScience (Nov 2021)

Rapamycin recruits SIRT2 for FKBP12 deacetylation during mTOR activity modulation in innate immunity

  • Lin Hu,
  • Fuxian Chen,
  • Chao Wu,
  • Jun Wang,
  • Si-si Chen,
  • Xiang-rong Li,
  • Jing Wang,
  • Linpeng Wu,
  • Jian-ping Ding,
  • Jian-chuan Wang,
  • Chao Huang,
  • Hui Zheng,
  • Yu Rao,
  • Yu Sun,
  • Zhijie Chang,
  • Wei Deng,
  • Cheng Luo,
  • Y. Eugene Chin

Journal volume & issue
Vol. 24, no. 11
p. 103177

Abstract

Read online

Summary: The mammalian target of rapamycin (mTOR) is a serine-threonine kinase involved in cellular innate immunity, metabolism, and senescence. FK506-binding protein 12 (FKBP12) inhibits mTOR kinase activity via direct association. The FKBP12-mTOR association can be strengthened by the immunosuppressant rapamycin, but the underlying mechanism remains elusive. We show here that the FKBP12-mTOR association is tightly regulated by an acetylation–deacetylation cycle. FKBP12 is acetylated on the lysine cluster (K45/K48/K53) by CREB-binding protein (CBP) in mammalian cells in response to nutrient treatment. Acetyl-FKBP12 associates with CBP acetylated Rheb. Rapamycin recruits SIRT2 with a high affinity for FKBP12 association and deacetylation. SIRT2-deacetylated FKBP12 then switches its association from Rheb to mTOR. Nutrient-activated mTOR phosphorylates IRF3S386 for the antiviral response. In contrast, rapamycin strengthening FKBP12-mTOR association blocks mTOR antiviral activity by recruiting SIRT2 to deacetylate FKBP12. Hence, on/off mTOR activity in response to environmental nutrients relies on FKBP12 acetylation and deacetylation status in mammalian cells.

Keywords